dalsy 20 mg/ml suspension oral
mylan ire healthcare limited - ibuprofeno - suspensiÓn oral - 20 mg/ml - ibuprofeno 20 mg - ibuprofeno
betahistina bgp 16 mg comprimidos efg
bgp products operations s.l. - betahistina dihidrocloruro - comprimido - 16 mg - betahistina dihidrocloruro 16 mg - betahistina
ibuprofeno bgp 600 granulado efervescente efg
bgp products operations, s.l. - ibuprofeno - excipientes: hidrogeno carbonato de sodio,sacarina sodica,sacarosa,laurilsulfato de sodio,carbonato de sodio anhidro,croscarmelosa sodica - productos antiinflamatorios y antirreumÁticos no esteroideos - derivados del ácido propiónico - ibuprofeno
dalsy 400 mg granulado efervescente
bgp products operations, s.l. - ibuprofeno - excipientes: sacarina sodica,sacarosa,laurilsulfato de sodio,hidrogenocarbonato de sodio,carbonato sodico,croscarmelosa sodica - productos antiinflamatorios y antirreumÁticos no esteroideos - derivados del ácido propiónico - ibuprofeno
kreon 40.000 u capsulas duras gastrorresistentes
bgp products operations, s.l. - lipasa, proteasa, amilasa - excipientes: capsulas de gelatina dura,cetilico, alcohol - digestivos, incluyendo enzimas - preparados enzimáticos - multienzimas (lipasa, proteasa, etc.)
klacid suspension 125
bgp products operations s.l. - claritromicina - granulado para suspensiÓn oral - 25 mg/ml - claritromicina 25 mg - claritromicina
klacid 50 mg/ml granulado para suspension oral
bgp products operations s.l. - claritromicina - granulado para suspensiÓn oral - 50 mg/ml - claritromicina 50 mg - claritromicina
betahistina bgp 16 mg comprimidos efg , 30 comprimidos
leponex 25 mg comprimidos
bgp products operations gmbh - comprimido - 25 mg
dapagliflozin viatris
viatris limited - dapagliflozin - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - drogas usadas en diabetes - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance. - in addition to other medicinal products for the treatment of type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 y 5. heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction. chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.